Who to follow: HealthTech executives
DS
Daniel Skovronsky, MD, PhD
Chief Scientific Officer · Eli Lilly and Company
Pharma & Life SciencesNorth AmericaEstablished
Why follow Daniel
The scientist behind Lilly's pipeline, including the EMBER-3 programme behind the Inluriyo approval.
Writes about
Drug discoveryOncologyClinical development
Best for
Readers who follow how big pharma R&D portfolios are built.